Concurrently, Moody’s affirmed its “A2” rating on the health system’s $370 million outstanding debt.
The assignment and affirmation are due to WakeMed’s strong market position, solid cash flow margins and good days cash on hand. Moody’s, however, expects the health system to remain leveraged.
The outlook is stable.
More articles on healthcare finance:
State-by-state breakdown of 102 rural hospital closures
10 hospitals seeking CFOs
How New York’s ‘baseball-style’ arbitration process reduced surprise bills: 7 notes
